Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma

• Published in: Pathology, research and practice Vol. 232; p. 153832
• Main Authors: Yoshizawa, Takahiro, Uehara, Takeshi, Iwaya, Mai, Asaka, Shiho, Kobayashi, Shota, Nakajima, Tomoyuki, Kinugawa, Yasuhiro, Nagaya, Tadanobu, Kamakura, Masato, Shimizu, Akira, Kubota, Koji, Notake, Tsuyoshi, Masuo, Hitoshi, Hosoda, Kiyotaka, Sakai, Hiroki, Hayashi, Hikaru, Umemura, Kentaro, Kamachi, Atsushi, Goto, Takamune, Tomida, Hidenori, Yamazaki, Shiori, Ota, Hiroyoshi, Soejima, Yuji
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.04.2022
• Subjects: Adenocarcinoma - pathology; Bile Duct Neoplasms; Bile Ducts, Intrahepatic - pathology; Cholangiocarcinoma; Humans; Intrahepatic cholangiocarcinoma; Leucine-rich repeat-containing G-protein-coupled receptor 5; Prognosis; Receptors, G-Protein-Coupled - genetics; RNA in situ hybridization; RNA in situ hybridization; Leucine-rich repeat-containing G-protein-coupled receptor 5; Intrahepatic cholangiocarcinoma
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2022.153832

Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is a known cancer stem cell marker. However, there are no reported analyses of LGR5 mRNA expression in normal liver and liver cancer tissues. Here, we evaluated LGR5 expression by RNAscope, a newly developed RNA in situ hybridization technique, using a tissue microarray consisting of 25 samples of intrahepatic cholangiocarcinoma (ICC) selected from the medical archives at our hospital. LGR5 expression levels were divided into high and low expression groups by the five-grade scoring system, and clinicopathological features were analyzed. Low LGR5 expression was identified in some normal hepatocytes and bile duct cells. In addition, LGR5 expression was identified in all bile duct cancer samples except one case. Well-differentiated to moderately-differentiated adenocarcinoma tended to show higher LGR5 expression than poorly-differentiated adenocarcinoma (P = 0.0561), and the large duct type showed significantly higher LGR5 expression levels than the small duct type (P = 0.0225). Patients in the high LGR5 expression group tended to have good overall survival (OS) (P = 0.0623). The Cox proportional hazard regression model revealed that the high LGR5 expression group showed independently better OS for ICC (P = 0.0285). High LGR5 expression is possibly a good prognosis factor in ICC. However, the detailed mechanism of LGR5 in this disease remains unclear, and further analysis is warranted.